Boston Research & Management Inc. Sells 7,029 Shares of Xylem Inc. $XYL

Boston Research & Management Inc. reduced its stake in shares of Xylem Inc. (NYSE:XYL) by 10.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 57,645 shares of the industrial products company’s stock after selling 7,029 shares during the period. Xylem comprises 1.8% of Boston Research & Management Inc.’s investment portfolio, making the stock its 14th biggest position. Boston Research & Management Inc.’s holdings in Xylem were worth $7,850,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of XYL. Knuff & Co LLC bought a new position in shares of Xylem during the 3rd quarter valued at approximately $27,000. Board of the Pension Protection Fund bought a new position in shares of Xylem during the 4th quarter valued at approximately $27,000. Commonwealth Retirement Investments LLC purchased a new stake in shares of Xylem during the 4th quarter valued at approximately $27,000. Wexford Capital LP purchased a new stake in shares of Xylem during the 3rd quarter valued at approximately $27,000. Finally, Ramirez Asset Management Inc. lifted its stake in shares of Xylem by 100.0% during the 3rd quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock valued at $30,000 after buying an additional 100 shares in the last quarter. 87.96% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of the stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the transaction, the chief accounting officer owned 3,605 shares of the company’s stock, valued at $423,443.30. This represents a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jerome A. Peribere bought 1,210 shares of Xylem stock in a transaction that occurred on Monday, May 4th. The stock was purchased at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the purchase, the director owned 27,209 shares of the company’s stock, valued at $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.32% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

XYL has been the topic of a number of recent research reports. Weiss Ratings cut shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Jefferies Financial Group restated a “hold” rating and set a $130.00 price target (down from $140.00) on shares of Xylem in a research note on Tuesday, March 31st. Mizuho set a $138.00 price target on shares of Xylem in a research note on Wednesday, February 11th. Robert W. Baird set a $161.00 price target on shares of Xylem in a research note on Wednesday, February 11th. Finally, UBS Group upped their price target on shares of Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a research note on Wednesday, April 29th. Seven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $152.77.

Xylem Stock Performance

NYSE XYL opened at $107.34 on Thursday. The company’s 50 day simple moving average is $116.24 and its two-hundred day simple moving average is $127.70. The stock has a market capitalization of $25.51 billion, a PE ratio of 26.70, a P/E/G ratio of 1.58 and a beta of 1.04. Xylem Inc. has a 1 year low of $105.29 and a 1 year high of $154.27. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10.

Xylem (NYSE:XYL) last announced its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.09 by $0.03. The company had revenue of $2.13 billion during the quarter, compared to analyst estimates of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The firm’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same period in the previous year, the business earned $1.03 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Analysts predict that Xylem Inc. will post 5.51 earnings per share for the current fiscal year.

Xylem announced that its Board of Directors has authorized a share buyback program on Wednesday, February 25th that allows the company to repurchase $1.50 billion in shares. This repurchase authorization allows the industrial products company to purchase up to 4.8% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s board believes its stock is undervalued.

Xylem Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Thursday, May 28th will be paid a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date of this dividend is Thursday, May 28th. Xylem’s dividend payout ratio is currently 42.79%.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.